Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 147.20 +0.40 (+0.27%)
As of 01/17/2025 12:06 PM Eastern

BBH vs. JGGI, 3IN, RCP, BPT, PHLL, MNKS, ABDN, HGT, SSON, and EMG

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include JPMorgan Global Growth & Income (JGGI), 3i Infrastructure (3IN), RIT Capital Partners (RCP), Bridgepoint Group (BPT), Petershill Partners (PHLL), Monks (MNKS), abrdn (ABDN), HgCapital Trust (HGT), Smithson Investment Trust (SSON), and Man Group (EMG). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Bellevue Healthcare (LON:BBH) and JPMorgan Global Growth & Income (LON:JGGI) are both financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership, community ranking and media sentiment.

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 4.1%. JPMorgan Global Growth & Income pays an annual dividend of GBX 23 per share and has a dividend yield of 3.8%. Bellevue Healthcare pays out 3,750.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JPMorgan Global Growth & Income pays out 2,643.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Bellevue Healthcare received 109 more outperform votes than JPMorgan Global Growth & Income when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 66.67% of users gave JPMorgan Global Growth & Income an outperform vote.

CompanyUnderperformOutperform
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%
JPMorgan Global Growth & IncomeOutperform Votes
2
66.67%
Underperform Votes
1
33.33%

JPMorgan Global Growth & Income has higher revenue and earnings than Bellevue Healthcare. JPMorgan Global Growth & Income is trading at a lower price-to-earnings ratio than Bellevue Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue HealthcareN/AN/AN/A£0.16920.00
JPMorgan Global Growth & Income£345.48M8.63£323M£0.87695.40

JPMorgan Global Growth & Income has a net margin of 93.49% compared to Bellevue Healthcare's net margin of 0.00%. JPMorgan Global Growth & Income's return on equity of 17.44% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Bellevue HealthcareN/A N/A N/A
JPMorgan Global Growth & Income 93.49%17.44%10.62%

40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 14.9% of JPMorgan Global Growth & Income shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by company insiders. Comparatively, 7.9% of JPMorgan Global Growth & Income shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, JPMorgan Global Growth & Income had 3 more articles in the media than Bellevue Healthcare. MarketBeat recorded 3 mentions for JPMorgan Global Growth & Income and 0 mentions for Bellevue Healthcare. JPMorgan Global Growth & Income's average media sentiment score of 1.31 beat Bellevue Healthcare's score of 0.00 indicating that JPMorgan Global Growth & Income is being referred to more favorably in the news media.

Company Overall Sentiment
Bellevue Healthcare Neutral
JPMorgan Global Growth & Income Positive

Summary

JPMorgan Global Growth & Income beats Bellevue Healthcare on 9 of the 14 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£804.67M£1.08B£3.81B£2.06B
Dividend Yield4.48%4.65%4.44%5.16%
P/E Ratio920.00814.30430.221,941.57
Price / SalesN/A1,490.922,705.22426,742.02
Price / CashN/A65.3752.6429.40
Price / BookN/A1.171.893.10
Net IncomeN/A£62.88M£362.35M£158.37M
7 Day Performance-0.27%1.80%2.88%3.24%
1 Month Performance7.60%1.83%3.73%2.60%
1 Year PerformanceN/A21.48%19.90%175.10%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 147.20
+0.3%
N/A-1.2%£804.67MN/A920.00N/APositive News
JGGI
JPMorgan Global Growth & Income
N/AGBX 594
+1.7%
N/A+22.2%£2.93B£345.48M682.76N/ANews Coverage
3IN
3i Infrastructure
N/AGBX 312.50
+0.8%
N/A-2.3%£2.88B£374M822.37N/A
RCP
RIT Capital Partners
N/AGBX 1,970
+0.5%
N/A+11.8%£2.83B£314.90M1,216.0562Insider Trade
News Coverage
BPT
Bridgepoint Group
0.9505 of 5 stars
GBX 341.60
+2.3%
GBX 334
-2.2%
+38.3%£2.81B£342.10M4,270.00391
PHLL
Petershill Partners
1.5627 of 5 stars
GBX 253
+2.4%
GBX 245.33
-3.0%
+76.6%£2.73B£578.70M1,100.00N/ANews Coverage
MNKS
Monks
N/AGBX 1,252
+0.3%
N/A+28.6%£2.53B£419.32M703.37N/ANews Coverage
ABDN
abrdn
1.5035 of 5 stars
GBX 133.60
-0.4%
GBX 155
+16.0%
-19.9%£2.38B£1.41B785.884,719News Coverage
HGT
HgCapital Trust
N/AGBX 515.53
+0.3%
N/A+22.7%£2.36B£255.96M1,031.07N/ANews Coverage
Positive News
SSON
Smithson Investment Trust
N/AGBX 1,454
+0.8%
N/A+10.1%£2.36BN/A640.53N/ANews Coverage
EMG
Man Group
2.6439 of 5 stars
GBX 203.60
-0.9%
GBX 291.17
+43.0%
-6.0%£2.34B£1.40B1,018.001,790Positive News

Related Companies and Tools


This page (LON:BBH) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners